Competition heating up among spore forming probiotics suppliers
Competition in the spore-forming quadrant of the probiotics sphere is heating up with a new offering from Nebraska Cultures called ProDURA, a strain of bacillus coagulans.
Archives for October 17, 2012
Dispatches from the Whole Grains on Every Plate conference
The rise and rise of whole grain: Whole Grain stamp now on 7,600+ products in 35 countries
The Whole Grain stamp now features on more than 7,600 products in 35 countries, while the number of new products featuring whole grain claims rose from 164 in 2000 to 3,378 in 2011, according to data unveiled at the Whole Grains on Every Plate conference...
Special Edition: Immune Support
Careful touch required in wording immune support label claims
How do you make claims on your immune product without raising regulators’ hackles? Take a tip from procreating porcupines and go very carefully, claims expert Ivan Wasserman advises.
Special edition: Immune support
Vitamin D’s immune benefits: Cold, flu and beyond
A recent study that dismissed the potential of the sunshine vitamin to reduce the incidence of the common cold should not dissuade consumers from seeking out the immune health benefits of the vitamin.
Special edition: Immune support
Immune sector in rude health despite regulator attacks
Foods, drinks, botanicals and other food supplements that boost the immune system have been one of the best performing functional sectors since, well, the birth of functional foods and supplements.
Special edition: immune support
Immune support in the -omics age: Moving away from old ideas of nutrition and immunity
The advent of new technologies and greater understanding of the mechanisms that regulate the complex interactions between nutrition and immunity is paving the way for industry to investigate new aspects of this complex relationship.
Special Edition: Immune Support
Immune support: Can fresh thinking on biomarkers and trials bring hope to industry claims?
Putting together a winning health claim dossier to EFSA has been a challenge for those in the immune support arena, but could new biomarkers and testing developments mean there is light at the end of the tunnel?